Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
Intern Med
; 62(14): 2085-2088, 2023 Jul 15.
Article
de En
| MEDLINE
| ID: mdl-36418104
Peripartum cardiomyopathy (PPCM) is a left ventricular systolic dysfunction associated with heart failure (HF) in late-term pregnancy or peripartum. A 29-year-old pregnant woman with no history of cardiac disease noted lower extremity edema around 34 weeks' gestation with significant weight gain. She delivered twins via caesarean section, and the edema regressed postpartum. On postpartum day 4, however, she experienced difficulty breathing at night and was diagnosed with HF owing to PPCM. HF treatment along with cabergoline was initiated. With low prolactin blood levels, her symptoms and cardiac function improved over time. This case demonstrated the usefulness of anti-prolactin therapy with cabergoline in PPCM.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Complications cardiovasculaires de la grossesse
/
Troubles du postpartum
/
Défaillance cardiaque
/
Cardiomyopathies
Limites:
Adult
/
Female
/
Humans
/
Pregnancy
Langue:
En
Journal:
Intern Med
Sujet du journal:
MEDICINA INTERNA
Année:
2023
Type de document:
Article
Pays d'affiliation:
Japon
Pays de publication:
Japon